CINCINNATI, Dec. 12, 2022 (GLOBE NEWSWIRE) — Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or the “Firm”), a biopharmaceutical firm growing transformational vaccines to handle important international well being challenges, immediately introduced its first analyst protection since going public in February 2022 with the preliminary suggestions as “purchase” from each Maxim Group LLC (“Maxim”) and H.C. Wainwright & Co. (“H.C. Wainwright”) at worth targets of $4 and $7, respectively.
Copies of the total analyst report from Maxim and H.C. Wainwright, respectively, may be obtained upon request straight from Maxim and H.C. Wainwright.
“We’re thrilled to obtain these suggestions from such esteemed analysts and actually imagine that each studies echo our inner beliefs about our groundbreaking expertise,” mentioned Joseph Hernandez, Chairman and Chief Govt Officer of Blue Water Vaccines. “Whereas we really feel that we’re undervalued within the present market, we imagine these studies spotlight our transformative vaccine applications to present and potential buyers and can hopefully present the true worth in our mission as we advance our applications in the direction of scientific trials.”
The analysis analysts primarily liable for the preparation of the Maxim and the H.C. Wainwright analysis studies have acquired compensation primarily based upon numerous elements, together with the respective agency’s whole revenues, a portion of which is generated by funding banking actions. Maxim makes a market in Blue Water Vaccines. Every of Maxim and HC Wainwright have acquired compensation for non-investment banking securities-related companies from Blue Water Vaccines prior to now 12 months and will present funding banking companies sooner or later. HC Wainwright has beforehand acquired compensation for funding banking companies within the final 12 months however does at the moment not make a market in Blue Water Vaccines.
Though BWV has paid the above compensation to the analysts, BWV shouldn’t be liable for the content material, accuracy or timelines contained in an analyst’s report and the payment was not depending on the opinion supplied.
All studies on BWV ready by analysts symbolize the views of such analysts and aren’t essentially these of BWV. BWV shouldn’t be liable for the content material, accuracy or timelines supplied by analysts. BWV doesn’t expressly or by implication warrant or assume any authorized legal responsibility or accountability for the accuracy, completeness, or usefulness of any data, assumption, knowledge, forecast, worth goal, estimate or projection contained within the studies or business notes supplied by analysts, and the dissemination of such studies or business notes doesn’t essentially represent or suggest BWV’s endorsement or suggestion.
About Blue Water Vaccines
Blue Water Vaccines Inc. is a biopharmaceutical firm targeted on growing transformational vaccines to handle important well being challenges globally. Headquartered in Cincinnati, OH, the corporate holds the rights to proprietary expertise developed on the College of Oxford, Cincinnati Youngsters’s Hospital Medical Middle, St. Jude Youngsters’s Hospital, and The College of Texas Well being San Antonio. The Firm is growing a common flu vaccine that may present safety from all virulent strains along with licensing a novel norovirus (NoV) S&P nanoparticle versatile virus-like particle (VLP) vaccine platform from Cincinnati Youngsters’s to develop vaccines for a number of infectious illnesses, together with norovirus/rotavirus and malaria, amongst others. Moreover, Blue Water Vaccines is growing a Streptococcus pneumoniae (pneumococcus) vaccine candidate, designed to particularly forestall the extremely infectious center ear infections, generally known as Acute Otitis Media (AOM), in youngsters, and prevention of pneumonia in older folks in danger for contracting pneumococcal pneumonia, a big unmet medical want. The benefit of this expertise features a serotype unbiased mucosal immunity that stops colonization within the higher respiratory tract in addition to systemic immunity that may confer serotype unbiased towards invasive pneumococcal illness The Firm can also be growing a Chlamydia vaccine candidate with UT Well being San Antonio to stop an infection and scale back the necessity for antibiotic remedy related to contracting Chlamydia illness. For extra data, go to www.bluewatervaccines.com.
Sure statements on this press launch are forward-looking inside the that means of the Non-public Securities Litigation Reform Act of 1995. These statements could also be recognized by means of forward-looking phrases comparable to “anticipate,” “imagine,” “forecast,” “estimate,” “count on,” and “intend,” amongst others. These forward-looking statements are primarily based on BWV’s present expectations and precise outcomes may differ materially. There are a variety of things that would trigger precise occasions to vary materially from these indicated by such forward-looking statements. These elements embody, however aren’t restricted to, dangers associated to the event of BWV’s vaccine candidates; the failure to acquire FDA clearances or approvals and noncompliance with FDA rules; delays and uncertainties attributable to the worldwide COVID-19 pandemic; dangers associated to the timing and progress of scientific improvement of our product candidates; our want for added financing; uncertainties of patent safety and litigation; uncertainties of presidency or third get together payor reimbursement; restricted analysis and improvement efforts and dependence upon third events; and substantial competitors. As with every vaccine below improvement, there are important dangers within the improvement, regulatory approval and commercialization of recent merchandise. BWV doesn’t undertake an obligation to replace or revise any forward-looking assertion. Buyers ought to learn the danger elements set forth in BWV’s Registration Assertion on Kind S-1, filed with the Securities and Change Fee (the “SEC”) on August 29, 2022 and periodic studies filed with the SEC on or after the date thereof. All of BWV’s forward-looking statements are expressly certified by all such danger elements and different cautionary statements. The knowledge set forth herein speaks solely as of the date thereof.
Media Contact Data:
Blue Water Media Relations
Phone: (646) 942-5591
Electronic mail: [email protected]
Investor Contact Data:
Blue Water Investor Relations
Electronic mail: [email protected]